Hendy Abdoul

Hendy Abdoul

Auto-generated profile, based on publicly available information

Hendy Abdoul

Hôpital Cochin Clinical Research Unit , Paris 75014

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Radiology
Verified
Journal Article
Closed access
MRMarie Pierre Revel
Marie Pierre Revel
SBSamia Boussouar
Samia Boussouar
CMConstance de Margerie-Mellon
Constance de Margerie-Mellon
ISInès Saab
Inès Saab
TLThibaut Lapotre
Thibaut Lapotre
HAHendy Abdoul
Hendy Abdoul
Using reverse transcription–polymerase chain reaction as the reference standard in 10 735 patients with suspected COVID-19 pneumonia, CT was 80% accurate and was also predictive of death or need fo... Background There are conflicting data regarding the diagnostic performance of chest CT for COVID-19 pneumonia. Disease extent at CT has been reported to influence prognosis. Purpose To create a lar...

23 June 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
JTJean-Laurent Thebault
Jean-Laurent Thebault
NRNicolas Roche
Nicolas Roche
HAHendy Abdoul
Hendy Abdoul
ALAlain Lorenzo
Alain Lorenzo
TSThomas Similowski
Thomas Similowski
CGChristian Ghasarossian
Christian Ghasarossian
Aim: To compare prednisone and placebo for the treatment of outpatients treated for acute exacerbations of chronic obstructive pulmonary disease (COPD) in a primary care setting.Methods: A multicentre, parallel, double-blind, pragmatic randomised controlled trial was performed in France. A total of 66 general practitioners included patients aged ≥40 years with cumulative smoking of ≥10 pack-years and a diagnosis of certain or likely acute exacerbation of COPD. Oral prednisone (40 mg) or placebo were administered daily for 5 days. The main outcome was treatment failure at 8 weeks, defined as a composite criterion based on the occurrence of at least one of the following: unplanned visit to an emergency department or to a practitioner in the ambulatory setting, hospital admission or death. The planned sample size was 202 patients per group.Results: 175 patients were included from February 2015 to May 2017 (43% of the planned sample). All-cause 8-week treatment failure rate was 42.0% in the prednisone group and 34.5% in the placebo group (relative risk 1.22, 95% CI 0.87–1.69, p=0.25). Respiratory-related 8-week treatment failure rate was 27.6% in the prednisone group and 13.6% in the placebo group (relative risk 2.00, 95% CI 1.15–3.57, p=0.015).Conclusion: Although the planned sample size was not achieved, the study does not suggest that oral corticosteroids are more effective than placebo for the treatment of an acute exacerbation of COPD in a primary care setting.

12 May 2023 in Annales Médico-psychologiques, revue psychiatrique
Verified
Journal Article
Closed access
HCHélène Chauvel
Hélène Chauvel
CSChiara Santini
Chiara Santini
CBCarine Layat Burn
Carine Layat Burn
LJLéa Jilet
Léa Jilet
HAHendy Abdoul
Hendy Abdoul
MPMarie-Aude Piot
Marie-Aude Piot

7 October 2026 in European Heart Journal - Cardiovascular Pharmacotherapy
Verified
Journal Article
Open access
LMLuca Monzo
Luca Monzo
HBHenri-Marc Becane
Henri-Marc Becane
YDYves Dulac
Yves Dulac
HAHelge Amthor
Helge Amthor
CCClaude Cances
Claude Cances
KWKarim Wahbi
Karim Wahbi

2 November 2026 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Open access
MGMathieu Gagnière
Mathieu Gagnière
JBJohann Beaudreuil
Johann Beaudreuil
ECEmmanuel Coudeyre
Emmanuel Coudeyre
HAHendy Abdoul
Hendy Abdoul
PAPhilippe Anract
Philippe Anract
CNChristelle Nguyen
Christelle Nguyen